Brandon Yu

Principal

As a member of ClearView’s leadership team, Brandon supports a broad range of life science and investor clients across pricing and market access, commercial, and corporate strategy. He has deep expertise across a variety of therapeutic areas with a focus in oncology, rare disease, immunology, and cell/gene therapies. He is also a leader within ClearView’s global pricing and market access practice, helping clients understand both U.S. (e.g., policy dynamics, single asset / portfolio pricing and contracting, health system implications), and global nuances in the EU, UK, APAC, and LATAM. In this role, Brandon prioritizes harmonizing commercial and P&MA strategy into high-impact strategy guidance for clients and their external audiences.

Prior to ClearView, Brandon supported both commercial and research functions within pharma at Pfizer, Merck, and the Johns Hopkins Hospital. Brandon earned his BSE in Chemical and Biomolecular Engineering from The Johns Hopkins University.